본문 바로가기
KERD
논문KCI 등재

Routine Chromosomal Microarray Analysis is Necessary in Korean Patients With Unexplained Developmental Delay/Mental Retardation/Autism Spectrum Disorder

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: All over the world, chromosomal microarray (CMA) is now the first tier diagnostic assay for genetic testing to evaluate developmental delay (DD), mental retardation (MR), and autism spectrum disorder (ASD) with unknown etiology. The average diagnostic yield of the CMA test is known to be about 12.2%, while that of conventional G-banding karyotype is below 3%. This study aimed to assess the usefulness of CMA for the purpose of clinical diagnostic testing in the Korean population. Methods: We performed CMA and multiplex ligation-dependent probe amplification (MLPA) tests in 96 patients with normal karyotype and unexplained DD, MR, or ASD. The CMA was conducted with CytoScan 750K array (Affymetrix, USA) with an average resolution of 100 kb. Results: Pathogenic copy number variations (CNVs) were detected in 15 patients by CMA and in two patients by MLPA for four known microdeletion syndromes (Prader-Willi/Angelman syndrome, DiGeorge syndrome, Miller-Dieker syndrome and Williams syndrome) designated by National Health Insurance system in Korea. The diagnostic yield was 15.6% and 2.1%, respectively. Thirteen (13.5%) patients (excluding cases with pathogenic CNVs) had variants of uncertain clinical significance. There was one patient with a 17.1-megabase (Mb) region of homozygosity on chromosome 4q. Conclusions: Our findings suggest the necessity of CMA as a routine diagnostic test for unexplained DD, MR, and ASD in Korea.

Abstract

Background: All over the world, chromosomal microarray (CMA) is now the first tier diagnostic assay for genetic testing to evaluate developmental delay (DD), mental retardation (MR), and autism spectrum disorder (ASD) with unknown etiology. The average diagnostic yield of the CMA test is known to be about 12.2%, while that of conventional G-banding karyotype is below 3%. This study aimed to assess the usefulness of CMA for the purpose of clinical diagnostic testing in the Korean population. Methods: We performed CMA and multiplex ligation-dependent probe amplification (MLPA) tests in 96 patients with normal karyotype and unexplained DD, MR, or ASD. The CMA was conducted with CytoScan 750K array (Affymetrix, USA) with an average resolution of 100 kb. Results: Pathogenic copy number variations (CNVs) were detected in 15 patients by CMA and in two patients by MLPA for four known microdeletion syndromes (Prader-Willi/Angelman syndrome, DiGeorge syndrome, Miller-Dieker syndrome and Williams syndrome) designated by National Health Insurance system in Korea. The diagnostic yield was 15.6% and 2.1%, respectively. Thirteen (13.5%) patients (excluding cases with pathogenic CNVs) had variants of uncertain clinical significance. There was one patient with a 17.1-megabase (Mb) region of homozygosity on chromosome 4q. Conclusions: Our findings suggest the necessity of CMA as a routine diagnostic test for unexplained DD, MR, and ASD in Korea.

참고문헌 (40)

  1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
  2. Battaglia A, "Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features", Eur J Paediatr Neurol, 17, pp.589~599 (2013)
  3. Weiss LA, "Association between microdeletion and microduplication at 16p11.2 and autism", N Engl J Med, 358, pp.667~675 (2008)
  4. Moeschler JB, "Clinical genetic evaluation of the child with mental retardation or developmental delays", Pediatrics, 117, pp.2304~2316 (2006)
  5. Miller DT, "Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies", Am J Hum Genet, 86, pp.749~764 (2010)
  6. Rauch A, "Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation", Am J Med Genet A, 140, pp.2063~2074 (2006)
  7. Wagenstaller J, "Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation", Am J Hum Genet, 81, pp.768~779 (2007)
  8. Bi W, "Comparison of chromosome analysis and chromosomal microarray analysis: what is the value of chromosome analysis in today’s genomic array era?", Genet Med, 15, pp.450~457 (2013)
  9. Kearney HM, "American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants", Genet Med, 13, pp.680~685 (2011)
  10. Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~423 (2015)
  11. Xiang B, "Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases", J Mol Diagn, 12, pp.204~212 (2010)
  12. Pinto D, "Copy-number variation in control population cohorts", Hum Mol Genet, 16(Spec No. 2), pp.R168~73 (2007)
  13. Glancy M, "Transmitted duplication of 8p23.1-8p23.2 associated with speech delay, autism and learning difficulties", Eur J Hum Genet, 17, pp.37~43 (2009)
  14. Parisi MA, "The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome", Am J Hum Genet, 75, pp.82~91 (2004)
  15. Adly N, "Ciliary genes TBC1D32", C6orf170 and SCLT1 are mutated in patients with OFD type IX, 2014, pp.35, 36~40
  16. Nowaczyk MJ, "Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology", Am J Med Genet C Semin Med Genet, 160C, pp.250~262 (2012)
  17. Weaver DD, "Cyclopia (synophthalmia) in Smith-Lemli-Opitz syndrome: first reported case and consideration of mechanism", Am J Med Genet C Semin Med Genet, 154C, pp.142~145 (2010)
  18. Vona B, "Terminal chromosome 4q deletion syndrome in an infant with hearing impairment and moderate syndromic features: review of literature", BMC Med Genet, 15, pp.72~ (2014)
  19. Bernardini L, "HDR (Hypoparathyroidism, Deafness, Renal dysplasia) syndrome associated to GATA3 gene duplication", Clin Genet, 76, pp.117~119 (2009)
  20. Cingoz S, "4q35 deletion and 10p15 duplication associated with immunodeficiency", Am J Med Genet A, 140, pp.2231~2235 (2006)
  21. Papenhausen P, "UPD detection using homozygosity profiling with a SNP genotyping microarray", Am J Med Genet A, 155A, pp.757~768 (2011)
  22. Rehder CW, "American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing", Genet Med, 15, pp.150~152 (2013)
  23. Middleton FA, "Complete maternal uniparental isodisomy of chromosome 4 in a subject with major depressive disorder detected by high density SNP genotyping arrays", Am J Med Genet B Neuropsychiatr Genet, 141B, pp.28~32 (2006)
  24. Ramanathan S, "A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R", BMC Med Genet, 5, pp.10~ (2004)
  25. Taylor CF, "Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA", Hum Mutat, 22, pp.428~433 (2003)
  26. Zhang X, "High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization", Am J Hum Genet, 76, pp.312~326 (2005)
  27. Wordsworth S, "Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom", Genomic Med, 1, pp.35~45 (2007)
  28. Trakadis Y, "Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis", Dev Med Child Neurol, 53, pp.994~999 (2011)
  29. Coulter ME, "Chromosomal microarray testing influences medical management", Genet Med, 13, pp.770~776 (2011)
  30. Roberts JL, "Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services", Gene, 535, pp.70~78 (2014)
  31. Nicholl J, "Cognitive deficit and autism spectrum disorders: prospective diagnosis by array CGH", Pathology, 46, pp.41~45 (2014)
  32. Bonaglia MC, "Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan", McDermid syndrome, 2011, pp.7, e1002173~
  33. Bonaglia MC, "Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome", Am J Hum Genet, 69, pp.261~268 (2001)
  34. Gong X, "High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability", PLoS One, 7, pp.e34739~ (2012)
  35. Lee KA, "The genetic testing system- Pending issues and future extensions", Medical Review, 11, pp.22~28 (2014)
  36. Thevenon J, "3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder", J Med Genet, 51, pp.21~27 (2014)
  37. Pehlivan T, "GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease", Am J Med Genet, 83, pp.201~206 (1999)
  38. Ballarati L, "Genotype-phenotype correlations in a new case of 8p23.1 deletion and review of the literature", Eur J Med Genet, 54, pp.55~59 (2011)
  39. DeScipio C, "Subtelomeric deletion of chromosome 10p15.3: clinical findings and molecular cytogenetic characterization", Am J Med Genet A, 158A, pp.2152~2161 (2012)
  40. Ullmann R, "Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and", or mental retardation, 2007, pp.28, 674~682

관련 논문AI추천

Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea권아름, 김명신, 김소영, 김용구, 김지연, 문연숙, 박주현, 박준홍, 성인경, 손정옥, 이상지, 이인구, 이정현, 장대현, 장우리, 채효진, 최하영, 한은희, 한지윤, 홍보영대한진단검사의학회 · Annals of Laboratory Medicine2019 · 제39권 제3호Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability황희, 김기중, 김수연, 우미정, 이진숙, 임병찬, 전종관, 채종희, 최영민, 최진선대한진단검사의학회 · Annals of Laboratory Medicine2018 · 제38권 제5호Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability김현주, 김효정, 박창일, 이경민, 임재우, 조은해연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제3호국내 단일기관 마이크로어레이검사 현황과 임상적 유용성 분석박희수, 임유진의학연구소 · 충북의대 학술지2024 · 제34권 제1호Regions of Homozygosity Identified with a Chromosomal Microarray in a Korean Population: Distribution, Frequency, and Clinical InterpretationKim Jaeryuk, Min Sunghee, Seo Eul-Ju, Seol Chang Ahn대한진단검사의학회 · Annals of Laboratory Medicine2026 · 제46권 제1호Comparing Two Diagnostic Laboratory Tests for Several Microdeletions Causing Mental Retardation Syndromes: Multiplex Ligation-Dependent Amplification vs Fluorescent In Situ Hybridization강유선, 조은해, 조정희, 박보야나대한진단검사의학회 · Annals of Laboratory Medicine2009 · 제29권 제1호

이 간행물의 다른 논문 (17건)